RDIF Links Companies and International Partners for Testing COVID-19
Posted on 03/16/2020
The Supervisory Board of the Russian Direct Investment Fund (RDIF) approved investment in a diagnosis system for the detection of the Wuhan coronavirus (COVID-19). RDIF claims the diagnosis for COVID-19 is fast and results can be in just 30 minutes.
According to the press release, “The system uses a SmartAmp isothermal molecular diagnostic method, where the technology provides results with accuracy comparable to real-time Polymerase Chain Reaction (PCR) analysis, while the speed of testing significantly exceeds PCR and does not require a stationary laboratory. This express testing system reflects successful cooperation between Russian and Japanese companies and scientists. Full scale use of the testing system is expected in April 2020.”
RDIF, through a network of international partnerships, has created an Expertise Centre for testing and implementing international practices to combat coronavirus, which will take into account the experience of Russia and foreign countries. The international experience in responding to the threat has been analyzed, with the best technological solutions selected at each stage to combat the virus, and the accumulated information has been transferred to the Federal Service for Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) and Coordinating Council for combating coronavirus under the Government of the Russian Federation.
In addition, RDIF partners from the UAE have made a donation to support the development of the Russian vaccine against COVID-19.
